Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Clinical trial NCT01344304 · COMPLETED

Trial details

NCT number: NCT01344304
Sponsor: Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2011-04-01
Primary completion: 2013-11-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.